Clinical trial · Interventional
Evaluation Study of SPOTme® Skin Cancer Screenings
NCT03564769CI-TRIAL-00040008completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AAD SPOTmeⓇ skin cancer screening | Other | — | UNRESOLVED |
| Intervention Arm | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Arm 1
- description
- Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials.
- interventionNames
- Behavioral: Intervention Arm
- Other: AAD SPOTmeⓇ skin cancer screening
- type
- EXPERIMENTAL
- label
- Intervention Arm 2
- description
- Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.
- interventionNames
- Other: AAD SPOTmeⓇ skin cancer screening
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participated in the American Academy of Dermatology national screening program in 2016 or 2017 * Have a presumptive diagnosis (screening, non-confirmed) of melanoma * Have provided the AAD with permission to be re-contacted * Have provided the AAD with an email address * Aged 18 years or older * Able to read English Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.